{"disease":{"id":"inflammatory-skin-disease","name":"inflammatory skin disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06794671","title":"A Basket Trial of Vunakizumab in Inflammatory Skin Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04215458","title":"Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Zealand University Hospital","has_results":false},{"nct_id":"NCT06874712","title":"Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04937101","title":"The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":78,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06448702","title":"Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04327752","title":"Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT05104723","title":"Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":20,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}